Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

To streamline early discovery, a cross-disciplinary, data-driven workflow process is key

Posted on February 23rd, 2018 by

“Complex” is the term that best describes the conditions that affect us. Whether it’s a disease or a consequence of a natural process such as aging, there are no simple fixes. Continue reading “To streamline early discovery, a cross-disciplinary, data-driven workflow process is key” »

Harnessing big data — it’s challenging, but it can be done

Posted on February 12th, 2018 by

Rubius logo

Today’s big data has the power to drive innovation in ways that the pharmaceutical industry could previously only dream of. Yet harnessing that power comes with an equally sizable challenge: it will require an enormous shift in how research is performed. Continue reading “Harnessing big data — it’s challenging, but it can be done” »

Pharma’s Path to Adopting AI and Other Emerging Technologies

Posted on February 7th, 2018 by

Right now in the pharmaceutical space, emerging technologies are dominating the conversation. As the cost of drug development soars, and the potential for success seems more and more elusive, the industry is pinning its hopes on promising technological breakthroughs. Continue reading “Pharma’s Path to Adopting AI and Other Emerging Technologies” »

Drug Development Insights from the 36th Annual J.P. Morgan Healthcare Conference

Posted on January 19th, 2018 by

The 2018 J.P. Morgan Healthcare Conference, held in San Francisco from January 8-11, came and went in a whirlwind. Continue reading “Drug Development Insights from the 36th Annual J.P. Morgan Healthcare Conference” »

  1. 1
  2. 2
  3. 3
  4. 54